Lung cancer is the leading cause of cancer-related mortality in the United States, and
accurate staging plays a vital role in determining prognosis and treatment. The recently …

Objectives To compare the diagnostic performance of 18 F-FDG PET/MRI and 18 F-FDG
PET/CT for primary and locoregional lymph node staging in non-small cell lung cancer …

Background: Accurate staging is crucial for the proper management of patients with
nonsmall cell lung cancer, especially for choosing the best treatment strategy. Different …

Lung cancer is the leading cause of cancer-related deaths worldwide, with a dismal 5-year
survival rate of 15%. The TNM (tumor-node-metastasis) classification system for lung cancer …

The International Association for the Study of Lung Cancer has reevaluated the staging
system for lung cancer. Their analysis reviewed data derived from more than 100,000 …

Therapeutic decisions in non–small cell lung cancer (NSCLC) patients depend on the tumor
stage. PET/CT with 18F-FDG is widely accepted as the diagnostic standard of care. The …

Lung cancer remains the leading cause of cancer-related mortality worldwide. To formulate
effective treatment strategies and optimize patient outcomes, accurate staging is essential …

Survival of lung cancer patients remains poor despite increasingly aggressive treatment.
Conventional staging has well-described limitations. 18F-FDG PET has been shown to …

Purpose This study aimed to explore the clinical staging performance of [68 Ga] Ga-DOTA-
FAPI-04 PET/CT compared with that of 2-[18F] FDG PET/CT in non-small cell lung cancer …

Integrated positron emission tomography/computed tomography (PET/CT) has many
advantages over solitary PET and CT, which has led it to become an increasingly …